About us

Chief Executive Officer

William Kilgallon, PhD, MBA

William has over 30 years of experience in the Pharmaceutical, Biotechnology and Diagnostic sectors encompassing SME and multi-national corporations. He has worked at senior vice president level covering Europe, USA, Latin America, Asia Pacific and Japan. William has completed a wide range of entrepreneurial projects including management buyouts, business turnarounds, trade sales and the securing of investments in the Biotech sector.

LinkedIn Profile

Chief Scientific Officer

Jon Gibbins, PhD

Professor of Cell Biology and Director of the Institute of Cardiovascular and Metabolic Research, University of Reading

Jon is an internationally acclaimed academic researcher in the field of platelet biology and translational research, and has contributed extensively to the discovery of key mechanisms of platelet regulation in health and disease. He has collaborated and published papers extensively with colleagues globally and served as founder and chair of the Platelet Society. Having authored over 200 research papers, Jon's 30 years of dedicated platelet research have culminated in the establishment of HaemAnalytica, driven by his unwavering commitment to advancing cardiovascular health.

LinkedIn profile

Chief Technical Officer

Chris Jones, PhD

Associate professor of Thrombosis and Haemostasis, University of Reading

Chris is a globally recognized scientist in the field of platelet function and signalling.

His groundbreaking research forms the cornerstone of HaemAnalytica, providing extensive expertise in measuring platelets in large cohorts and clinical studies. This has resulted in a profound understanding of patient phenotyping through AI and has laid the groundwork for improving platelet services leading to personalized medicine.

LinkedIn Profile

Chief Operating Officer

Gemma Little, PhD

Gemma started developing point-of-care devices to measure platelet function after completing her undergraduate degree in Biomedical Sciences, before completing her PhD investigating the role of HSP47 on platelets and their precursor, megakaryocytes. She is experienced in platelet function analysis, advanced microscopy techniques, and cell based assays. Gemma has worked with HaemAnalytica technologies since their development in the lab during her PhD and will use her scientific background to ensure HaemAnalytica products and services align with market needs.

LinkedIn Profile

Chief Financial Officer

Jeremy Rowson, PhD, MBA

Jeremy has held CEO/COO/board positions with both private and public multinational companies in the UK, UAE, Brazil, the Philippines, Hong Kong and New Zealand. His business experience includes, business development, international investments, mergers, acquisitions and company divestments, turnarounds, leveraged management buyouts and startups.

LinkedIn Profile